Scientific Liaison, Merck Sharpe & Dohme
Rob joined Merck's licensing team in Sept 2007 and since mid 2008 his remit is to identify
partnering opportunities in the UK, Ireland, Portugal & Spain.
Before joining Merck Rob worked for a year in Cambridge University on neuronal injury &
prosthetics. He spent time in Biotech between 2004-6, advancing programs in CV, metabolic
disease & pain from concept to clinic.
Previously he held positions of increasing seniority in
Parke Davis, Cambridge, UK, until their acquisition by Pfizer.
In 2001 he moved to Pfizer
research laboratories in Ann Arbor, Michigan, as senior director for CNS Molecular Science.
Collaborations were an important part of Rob's mandate at Parke-Davis / Pfizer.
joined the pharmaceutical industry Rob trained in Southampton & spent several years as a
research fellow at the MRC and University of Cambridge.